Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
ANI Pharmaceuticals (ANIP) PT Lowered to $30 at Cantor Fitzgerald
-
Greystone Boosts CMBS Platform with New Hires
-
Tims China Confirms Financing Commitment
-
Cantor Fitzgerald Reiterates Novan (NOVN) at Overweight, Sees EPI Acquisition as "Smart and Significant Move"
-
HCM Acquisition Corp Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on March 14, 2022
-
HCM Acquisition Corp Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on March 14, 2022
-
Cantor Fitzgerald Reiterates Overweight Rating on AxoGen (AXGN)
-
Kalvista Pharmaceuticals Inc (KALV) PT Lowered to $33 at Cantor Fitzgerald
-
Cantor Fitzgerald and Silverstein Properties Close Third Qualified Opportunity Zone Fund, Approximately $600 Million of Total Capital Raised
-
Cantor Fitzgerald Reiterates TherapeuticsMD (TXMD) at Overweight, "TXMD's Opportunity to Become Leading Women's Healthcare Company Remains Underappreciated"
-
Troika Media (TRKA) Enters Firm Commitment for a $75M Senior Secured Credit Facility with Institutional Investor to Fund the Acquisition of Converge Direct LLC
-
Troika Media Group Signs a Firm Commitment for a $75 Million Senior Secured Credit Facility with a Multibillion-Dollar Institutional Investor to Fund the Acquisition of Converge Direct LLC
-
Troika Media Group Signs a Firm Commitment for a $75 Million Senior Secured Credit Facility with a Multibillion-Dollar Institutional Investor to Fund the Acquisition of Converge Direct LLC
-
Mustang Bio to Participate in Three March 2022 Investor Conferences
-
Mustang Bio to Participate in Three March 2022 Investor Conferences
-
springbig Announces 2021 Financial Highlights and Nominees for Post-Business Combination Board of Directors
-
Heron Therapeutics (HRTX) and Omeros (OMER) Top Cantor Fitzgerald's Most Shorted List; Amgen (AMGN) and PDS (PDSB) Seeing Biggest Increases
-
Brooklyn ImmunoTherapeutics Announces Closing of $12 Million Private Placement
-
Acadia Pharmaceuticals (ACAD) PT Raised to $37 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Lipocine (LPCN) at Overweight, Company's Pipeline Assets and Peak Sales Opportunities are Underappreciated
-
Fortress Biotech to Participate in Three March 2022 Investor Conferences
-
Fortress Biotech to Participate in Three March 2022 Investor Conferences
-
AGTC to Participate in Upcoming Investor Conferences
-
AGTC to Participate in Upcoming Investor Conferences
-
Mustang Bio Completes a $75 Million Debt Financing with Runway Growth Capital
-
Mustang Bio Completes a $75 Million Debt Financing with Runway Growth Capital
-
Iris Energy Limited Announces Monthly Investor Update for February 2022
-
Iris Energy Limited Announces Monthly Investor Update for February 2022
-
SatixFy to Go Public via Combination with Endurance Acquisition Corp. (EDNC)
-
SatixFy, a Leader in Next-Generation Satellite Communication Systems, to Go Public via Combination with Endurance Acquisition Corp.
-
Cantor Fitzgerald Reiterates Cidara Therapeutics (CDTX) at Overweight, Believes the Street Underappreciates Company's Sales Potential, Sees Upward Earnings Revisions
-
Alpha Tau Medical and Healthcare Capital Corp. Announce Completion of Business Combination
-
Brooklyn ImmunoTherapeutics Announces $12 Million Private Placement
-
Cantor Fitzgerald Reiterates TherapeuticsMD (TXMD) at Overweight, $5 PT, VitaCare Sale is Good News, Priced Above Expectation, Increases Confidence in the Stock
-
Cantor Fitzgerald Reiterates VYNE Therapeutics (VYNE) at Overweight, Newest Data Supports Positive Thesis for Stock
-
Atlantic Coastal Acquisition Corp. II Announces the Separate Trading of its Shares of Series A Common Stock and Warrants Commencing March 7, 2022
-
Cantor Fitzgerald Reiterates Overweight Rating on Evolus (EOLS), Jeuveau's Value Proposition is Underappreciated
-
Curaleaf (CURLF) PT Lowered to $15.50 at Cantor Fitzgerald
-
Hexo Corp. (HEXO:CN) (HEXO) PT Lowered to Cdn$0.90 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Hutchison China MediTech Ltd. (HCM) at Overweight, Believes HCM's Pipeline is Underappreciated
-
Cantor Fitzgerald Reiterates EyePoint (EYPT) at Overweight, Believes Potential Peak Sales for EYP-1901 Remains Underappreciated
-
Cantor Fitzgerald Reiterates Entasis Therapeutics (ETTX) at Overweight, Believes More Value to Unlocked in Shares
-
Form 8-K Cantor Fitzgerald Income For: Mar 01
-
McEwen Mining Closes Flow-Through Financing
-
McEwen Mining Closes Flow-Through Financing
-
Cantor Fitzgerald Reiterates Avalo (AVTX) at Overweight, Peak Sales Potential of Pipeline is Underappreciated
-
Graphite Corp. (GRPH) Appoints Alethia Young as Chief Financial Officer
-
Graphite Bio Appoints Alethia Young as Chief Financial Officer
-
10X Capital Venture Acquisition Corp. III Announces the Separate Trading of its Ordinary Shares and Warrants, Commencing March 4, 2022
-
10X Capital Venture Acquisition Corp. III Announces the Separate Trading of its Ordinary Shares and Warrants, Commencing March 4, 2022

